With a different method for gene therapy, Generation Bio eyes an IPO

With a different method for gene therapy, Generation Bio eyes an IPO

STAT Plus: Startup Spotlight: With a different method for gene therapy, Generation Bio eyes an IPO

By KATE SHERIDAN

ALEX HOGAN/STAT

Generation Bio, one of the privately held startups presenting at J.P. Morgan, is hoping it will be able to create gene therapies for the masses.

READ MORE